000 02226nam  2200421zi 4500
0019.891862
003CaOODSP
00520240209135304
006m     o  d f      
007cr cn|||||||||
008200928e202010  onca    ob   f000 0 eng d
020 |a9780660361062
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-277/2020E-PDF
24500|aRecommendations on the duration of the post-vaccination observation period for influenza vaccination during the COVID-19 pandemic.
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cOctober 2020.
264 4|c©2020
300 |a1 online resource (40 pages) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Recommandations sur la durée de la période d'observation post-vaccinale pour la vaccination antigrippale pendant la pandémie de COVID-19.
500 |aAt head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI).
500 |a"Pub.: 200209."
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references (pages 38-40).
650 0|aInfluenza|xVaccination|zCanada.
650 0|aInfluenza|xVaccination|xComplications|zCanada.
650 0|aCOVID-19 Pandemic, 2020-|zCanada.
650 0|aCOVID-19 (Disease)|zCanada|xPrevention.
7102 |aPublic Health Agency of Canada, |eissuing body.
7101 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body.
77508|tRecommandations sur la durée de la période d'observation post-vaccinale pour la vaccination antigrippale pendant la pandémie de COVID-19.|w(CaOODSP)9.891866
85640|qPDF|s2.45 MB|uhttps://publications.gc.ca/collections/collection_2021/aspc-phac/HP40-277-2020-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-duration-observation-period-post-influenza-vaccination-during-covid-19-pandemic.html